Hot Watch List: Apple Inc. (NASDAQ:AAPL), Twitter Inc (NYSE:TWTR), Gilead Sciences, Inc. (NASDAQ:GILD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Apple Inc. (NASDAQ:AAPL)’s resurgent stock may have as much to do with financial engineering as the company’s technological wizardry. Monday marked Apple Inc. (NASDAQ:AAPL)’s first stock split in nine years, a move designed to make it more affordable to buy shares of the iPhone and iPad maker. Apple Inc. (NASDAQ:AAPL) stock performance was 1.60% in last session and finished the day at $93.70. Traded volume … Continue reading Hot Watch List: Apple Inc. (NASDAQ:AAPL), Twitter Inc (NYSE:TWTR), Gilead Sciences, Inc. (NASDAQ:GILD), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Biotech unusual volume stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), BioDelivery Sciences International (NASDAQ:BDSI), ImmunoCellular Therapeutics (NYSEMKT:IMUC), Anika Therapeutics (NASDAQ:ANIK)

AbbVie may now consider a takeover of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), a $411 million company, to expand in that market, Redmond said. Shares of Achillion rallied (ACHN:US) as much as 67 percent yesterday. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was 47.57% in last session and finished the day at $4.25. Traded volume was 47.79million shares in the last session and the average volume of the … Continue reading Biotech unusual volume stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), BioDelivery Sciences International (NASDAQ:BDSI), ImmunoCellular Therapeutics (NYSEMKT:IMUC), Anika Therapeutics (NASDAQ:ANIK)

Insys Therapeutics, Inc. (NASDAQ:INSY)’s shares have been under pressure recently on news regarding prescribing patterns for Subsys. The stock price of the company tumbled 17.41% and 15.45% in the last two consecutive trading sessions. Insys Therapeutics Inc (NASDAQ:INSY) stock performance was -15.70% in last session and finished the day at $23.01. Traded volume was 3.24million shares in the last session and the average volume of … Continue reading Biotech Losers: Insys Therapeutics Inc (NASDAQ:INSY), Enzymotec Ltd (NASDAQ:ENZY), Geron Corporation (NASDAQ:GERN), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Cytokinetics, Inc. (NASDAQ:CYTK) announced disappointing top-line results from its BENEFIT-ALS midstage study involving tirasemtiv. Tirasemtiv did not meet its primary efficacy endpoint of delivering a mean change from baseline in the ALS functional rating scale. Cytokinetics, Inc. (NASDAQ:CYTK) stock performance was -64.67% in last session and finished the day at $4.59. Traded volume was 17.26million shares in the last session and the average volume of … Continue reading Healthcare Losers: Cytokinetics (NASDAQ:CYTK), Achillion Pharmaceuticals (NASDAQ:ACHN), Pharmacyclics (NASDAQ:PCYC), Organovo Holdings Inc (NYSEMKT:ONVO)

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) was upgraded by investment analysts at Maxim Group from a “hold” rating to a “buy” rating in a note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm currently has a $6.00 price target on the stock. Maxim Group’s target price would suggest a potential upside of 62.16% from the stock’s previous close. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -7.30% … Continue reading Biotech Bearish Stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Galena Biopharma (NASDAQ:GALE), Insmed Incorporated (NASDAQ:INSM), CytRx Corporation (NASDAQ:CYTR)

Novavax, Inc. (NASDAQ:NVAX) is a vaccine company that is likely to have multiple milestones this year. It has U.S. government funding for seasonal and pandemic flu, and is developing its own products for respiratory syncytial virus (RSV). Novavax, Inc. (NASDAQ:NVAX) stock performance was -5.02% in last session and finished the day at $6.05. Traded volume was 4.36million shares in the last session and the average … Continue reading Biotech Losers: Novavax (NASDAQ:NVAX), Achillion Pharmaceuticals (NASDAQ:ACHN), The Clorox (NYSE:CLX), Halozyme Therapeutics (NASDAQ:HALO)